CILcare specializes in providing drug solutions for hearing and ear disorders.
CILcare has raised $42.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
CILcare's investors include Shionogi, The University of Vermont Health Network, SPRIM Global Investments, Sofilaro, Aris Occitanie.
CILcare is headquartered in Montpellier, France.
CILcare specializes in providing drug solutions for hearing and ear disorders.
CILcare is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CILcare — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/cilcare. Accessed September 14, 2026.
VCBacked. (2024). CILcare — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/cilcare
{{cite web |title=CILcare — Funding & Investors |url=https://www.vcbacked.co/company/cilcare |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated